throbber
Journal of Chromatography, 389 (1987) 165-176
`Elsevier Science Publishers B.V., Amsterdam — Printed in The Netherlands
`
`CHROM. 19 176
`
`COLUMN CHROMATOGRAPHIC PURIFICATION OF GUANYLATE-RICH
`SYNTHETIC OLIGODEOXYRIBONUCLEOTIDES
`
`HERBERT SCHOTT*, ROLF SEMMLER and HEINER ECKSTEIN
`Institut fiir Organische Chemie, Universitat Tiibingen, Auf der Morgenstelle 18, D-7400 Tiibingen-1
`(FLR.G.)
`(Received October 20th, 1986)
`
`SUMMARY
`
`The purification of the guanylate-rich DNA fragments d(T4G4), d(G4T4),
`d(G4T4G4), d(T4G4T,4) and d(T,G,T4G,) using column chromatography ona pre-
`parative scale is described. The crude oligonucleotides were obtained after deprotec-
`tion of the chemically synthesized compounds. The separation can be performed with
`commonly used sorbents (DEAE-cellulose, QAE-Sephadex, Nucleosil C,,. Partisil
`10-SAX), however with high losses during the chromatography. Guanylate-rich oli-
`gonucleotides of different chain lengths associate with each other, thus causing iden-
`tical compounds to be contained within different peaks. At the same time, part of
`the product remains irreversibly adsorbed on the sorbent. The recoveries could be
`improved by application of ion-pair reversed-phase high-performance liquid chro-
`matography. Theoligonucleotides were fractionated with linear increasing gradients
`using acetonitrile as the organic modifier and tetrabutylammonium hydrogensulphate
`as the ion-pair reagent.
`
`INTRODUCTION
`
`The synthesis of guanylate-rich DNA fragments is much more laborious than
`the synthesis of comparable oligonucleotides, which contain only few or no guanylate
`monomer units in their sequences, Besides distinctly lower yields obtained in the
`condensation reaction, there are additional difficulties in separation, isolation and
`identification, which have not been solved.
`We have synthesized the guanylate-rich oligonucleotides d(T4Ga4), d(G4T4),
`d(G4T4G,q4), d(T4G4T4) and d(T4G4T4G,4) in preparative amounts. These oligonu-
`cleotides correspond to fragments of the terminus of the macronuclear DNA of hy-
`potrichous ciliates'~°. The syntheses were carricd out in solution according to the
`phosphotriester method and will be published elsewhere’. The same oligonucleotides
`were preparedin three ways, applying differently protected guanylate monomerunits.
`The results of thirty different condensation reactions, several of which have been
`performed repeatedly, may be summarized as follows: the synthesis and isolation of
`the protected guanylate-rich oligonucleotides can be achieved in gram amounts. The
`
`0021-9673/87/$03.50
`
`© 1987 Elsevier Science Publishers B.V.
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 1
`Page 1
`
`

`

`166
`
`H. SCHOTT, R. SEMMLER, H. ECKSTEIN
`
`condensation reactions result in good yields, which are essentially independent of the
`kind of protecting groups and of the choice of the agents used for the condensation.
`However, serious difficulties arise during the chromatographic purification of the
`deblocked oligonucleotides as will be reported in this paper.
`
`EXPERIMENTAL
`
`Materials
`Sephadex G-15- and QAE-Sephadex A-25 were obtained from Pharmacia
`(Uppsala, Sweden), DEAE-cellulose from W. R. Balstone (Maidstone, U.K.), Dowex
`50W-X8 from Serva (Heidelberg, F.R.G.) and Nucleosil 7 C,g from Macherey &
`Nagel (Diiren, F.R.G.). Tetrabutylammonium hydrogensulphate (TBA)for ion-pair
`chromatography was from Merck (Darmstadt, F.R.G.).
`
`Fractionation
`Column chromatography of the deprotected oligonucleotides. The deprotected
`oligonucleotides were fractionated on DEAE-cellulose or QAE-Sephadex at a flow-
`rate of 200 ml/h, according to the conditionslisted in Table I. Fractions of about 20
`ml were collected. The absorbance of every fifth fraction was measured at 250, 260
`and 280 nm. The values measured at 260 nm wereplotted versus the elution volume
`(Fig. 1). Fractions were collected within the vertical dotted lines of Fig. 1. On re-
`peated addition of pyridine,
`the volatile triethylammonium hydrogencarbonate
`(TEAB) was removed in vacuo. The pyridine was removed by co-evaporation with
`3% aqueous ammonia. Finally the remaining solution was lyophilized. The sodium
`chloride-Tris-HClI buffer was removed by gel chromatography on a Sephadex G-15
`column, In order to remove the urea, the combined peak fractions were diluted to
`1:2.5 in water and pumped on a DEAE-Sephadex column (40 cm * 2 cm) previously
`equilibrated with water. The column was washed with water until free of chloride,
`and wastheneluted with a 1 M sodium chloride solution. The oligonucleotides eluted
`with the salt were desalted by gel chromatography and lyophilized.
`High-performance liquid chromatography (HPLC) of the deprotected oligonu-
`cleotides. HPLC was performed according to the conditions summarized in Table II
`on an analytical column (250 mm x 4.6 mmm I.D.) and a preparative column (250
`mm * 8mm J.D.) equipped with a precolumn (30 mm x 8 mm I.D.) packed with
`Nucleosil 7 C,g. Experiments 1—3 of Table II were carried out at room temperature,
`4-6 at 50°C. One A260 unit of the oligonucleotide was dissolved in !—-10 ul water and
`applied to the column. The combined fractions were desalted as follows: the TBA
`solution obtained was added to 50 ml dichloromethane. A saturated aqueous picric
`acid solution was added dropwise to the stirred mixture until the aqueous layer had
`becomeslightly yellow. After separation of the layers, the aqueous phase wastreated
`with Dowex 50W-X8 (H*) and chromatographed on a Sephadex G-15 column (40
`em * 4cm). The fractions containing product were combined, evaporated to dryness
`in vacuo and lyophilized.
`HPLC of d(T4G4T4G4) after total hydrolysis by formic acid. One A269 unit of
`d(T4G4T4Ga4) was treated with 500 pl of 90%formic acid at 170°C during 45 min.
`The reaction mixture was lyophilized and dissolved in about 200 pl of 50 mM
`aqueous ammonium acetate (pH 6.8). About 0.10 Ag¢o units of this solution were
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 2
`Page 2
`
`

`

`PURIFICATION OF OLIGODEOXYRIBONUCLEOTIDES
`
`167
`
`TABLE |
`
`CHROMATOGRAPHIC PURIFICATION OF PROBES (DISSOLVED IN WATER) OBTAINED AFTER THE
`DEPROTECTION OF THE PROTECTED DODECAMERS AND HEXADECAMERS USING DEAE-CEL-
`LULOSE (EXPERIMENTS 1, 2, 3a, 4) OR QAE-SEPHADEX (EXPERIMENT 3)
`The columns (diameter 2 cm) were eluted with increasing salt concentration using triethylammonium hydrogencar-
`bonate (pH 7.8) (A) or sodium chloride-0.05 M Tris-HCl (pH 7.6) + 7 M urea (B).
`
`Experi-—Deprotected Applied Column—Elution conditions
`
`
`ment
`oligonu-
`probe
`lengih
`o
`No.
`cleotide
`{Ax6o0
`fem}
`Temper-
`units/ml)
`ature
`CC)
`
`Volume (1) and
`salt concentration (M)*
`oe
`Mixing
`Reser-
`vessel
`voir
`
`
`Eluent
`
`Step
`No.
`
`**
`
`TaGaTq
`
`10 200/300
`
`50
`
`2
`
`3
`
`GaTaGa
`
`4500/150
`
`TyGaT4Gu
`
`14 500/350
`
`25
`
`25
`
`3a
`
`T4GuTyG,***
`
`3900/100
`
`25
`
`4
`
`TyGaTsGy
`
`6700/200
`
`25
`
`50
`
`25
`
`25
`
`50
`
`50
`
`I
`2
`3
`4
`
`1
`2
`3
`
`I
`2
`3
`4
`
`I
`2
`3
`4
`
`l
`2
`3
`4
`
`1.0, 0.05
`B
`2.0, 0.05
`B
`2.0, O15
`B
`1 M NaCl 1.0
`
`A
`A
`A
`
`1.0, 0.10
`2.0, 0.10
`0.5, 1.0
`
`1.0, 0.05
`B
`2.0, 0.05
`B
`1.0, 0.5
`B
`1 M NaCl 0.7
`
`1.0, 0.05
`B
`2.0, 0.05
`B
`1.5, 0.20
`B
`1 M NaCl 1.0
`
`1.0, 0.05
`B
`2.0, 0.05
`B
`1.8, 0.20
`B
`1 M NaC! 1.0
`
`_
`2.0, 0.15
`2.0, 0.30
`_
`
`2.0, 0.40
`—
`
`=
`2.0, 0.50
`
`_
`2.0, 0.20
`1.8, 0.35
`
`—
`2.0, 0.20
`1.5, 0.35
`
`* WhenBis used as the eluent M refers only to the sodium chloride concentration.
`** The total amounts of deprotected oligonucleotides were chromatographed in three experiments,
`*** Rechromatography of the mixture of d(T,4G,) and d(T,G4T4G,)isolated from experiment 3.
`
`fractionated on a Nucleosil 7 C,g column (250 mm x 4.6 mm I.D.) with 50 mA¢
`ammonium acetate (pH 6.8) as the eluent (see Fig. 5).
`
`RESULTS AND DISCUSSION
`
`The DNAfragments d(G4T4G4), d(T4G4T4) and d(T4G4T4,G,4) were obtained
`from the corresponding fully protected oligonucleotides after cleavage of the pro-
`tecting groups and chromatographic separation of the oligonucleotides. The crude
`product d(T4G4T,4), obtained after deprotection of 1.05 g dodecamer, wasfraction-
`ated on DEAE-cellulose in three portions, employing a linear increasing gradient of
`sodium chloride containing 7 M urea at 50°C, as indicated in Table I (experiment1),
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 3
`Page 3
`
`

`

`H. SCHOTT. R. SEMMLER, H. ECKSTEIN
`
`
`aso
`
`aso
`
`030
`
`=£
`
`az
`O10
`3
`aos
`
`
`
`
`
`168
`
`oa=
`
`2
`a
`
`”
`g
`<=
`
`
`
`O40
`
`—
`030 7
`oS
`020 £“
`
`8
`aio
`oo 2
`
`040
`
`_
`030 7
`°o
`a20 £‘
`aw 6
`oo 2
`
`Elution vol,
`
`in l
`Fig. 1. Chromatographic purification of d(T,G4T4Gyq) resulting after deprotection of the protected hexa-
`decanucleotides, which were synthesized using different strategies. (a) Fractionation (experiment 3, Tables
`1, III) ofthefirst hexadecanucleotide d(T,G,T4G,4) on a QAE-Sephadex columnat 25°C with an increasing
`sodium chloride gradient, buffered to pH 7.6 by 0.05 Mf Tris-HCL (b) Rechromatographyof the mixture
`corresponding to peak II resulting from (a) on a DEAE-cellulose column (experiment 3a, Tables 1, ID)
`at 50°C with an increasing sodium chloride gradient in 7 M urea, buffered to pH 7.6 by 0.05 M Tris-HCl.
`(c) Fractionation (experiment 4, Tables.I, IIT) of the second hexadecanucleotide d(T4G4T,G,) using the
`same conditionsas in (b). Column: 25cm * 2 cm. Flow-rate: 200 ml/h. Within the dotted lines, fractions
`of peaks I and II were pooled, desalted and lyophilized.
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 4
`Page 4
`
`

`

`PURIFICATION OF OLIGODEOXY RIBONUCLEOTIDES
`
`169
`
`TABLE Il
`
`CONDITIONS AND RESULTS OF ION-PAIR REVERSED-PHASE HPLC OF OLIGONUCLEOTIDES ON
`A NUCLEOSIL 7 C,, COLUMN (LENGTH 250 mm)
`
`Eluents: A = 7.5 mM tetrabutylammonium hydrogensulphate (TBA) pH 7.0: B = 7.5 mf TBA pH 7.0 in 75%
`aqueous acetonitrile, C = 5 mAf TBA pH 6.8; D = $ mM TBA pH 6.8 in 70%aq. acetonitrile.
`
`
`
`
`Experi-|Chromatographed oligonucleotides Column Elution Retention Fig.
`
`~
`-
`-
`ment
`~
`diameter
`conditions
`hme
`Yield
`No.
`Designation
`Amount
`(mum)
`fin}
`fAr60
`(%}
`units)
`
`
`
`
`d(G4T4)
`d(T4GsT4)
`d(T.G4T4)
`
`60.0
`2.5
`50.0
`
`91
`98
`94
`
`8.0
`4.6
`8.0
`
`70%A, 30%B
`50% A, 50% B
`50%A, 50% B
`
`9.23
`12.92
`12.22
`
`2a
`=
`2b
`
`d(T4Gq)
`d(GgTsGq)
`
`0.5
`0.3
`
`92
`60
`
`4.6
`4.6
`
`26,22
`31.78
`
`3a
`3b
`
`60% C, 40% D
`changed within
`48 min to
`
`d(TsG4T4Gq) 3c 0.3 9] 4.6 20% C, 80% D 36.23
`
`
`
`
`
`
`
`1
`2
`3
`
`4
`5
`
`6
`
`
`
`
`
`Of the Azo units applied to the column, 39% were due to d(T4G4T4) and 18% to
`d(G4T4) . The remaining 43%consisted of removed protecting groups and ofseveral
`oligonucleotides of shorter chain length. Fractions which contained d(T4G,4T4) or
`d(G,T,) from three experiments were pooled and worked up, thus giving 351 mg of
`dadecamers and 150 mg of octamer. On the basis of the fully protected dodecamer,
`the yield of d(T4G4T4) was 53%.
`The crude productof the second dodecamer d(G4T4G4) was also fractionated
`by means of DEAE-cellulose. When a small quantity of dodecamer d(G4T4G,4) was
`chromatographed on a DEAE-cellulose column, no clear peaks could be detected in
`the region of the dodecamer. This result was quite a surprise, especially since the
`formation of a fully protected condensation product had been confirmed by thin-
`layer chromatography. After the deprotection of 600 mg of the corresponding pro-
`tected d(G4T4G,4), preparative chromatography (experiment 2, Table I) could be
`performed only with a considerable loss of oligonucleotides. Contrary to the pre-
`viously described fractionation of d(T4G4T4), the column was eluted with an increas-
`ing concentration oftriethylammonium hydrogencarbonate buffer (TEAB) at 25°C.
`The oligonucleotide leaving the column at a salt concentration of 0.35—-0.39 M was
`identified as d(T,4G4). The required dodecamer d(G4T4G,4) wasfinally eluted by 1 M
`TEAB (see Table III). 15%of the applied Azo units were due to d(T4G4) and 20%
`to d(G4T4G,4). On working up the pooled fractions, 20 mg d(T4G,4) and 30 mg
`d(G4T4G4) were obtained correspondingto a yield of only 8% in relation to the fully
`protected dodecamer.
`This rather low yield might be explained by assuming that part of the dode-
`camer was degradated during the cleavage of the protecting groups. This explains the
`elution of numerous short-chain oligonucleotides. Another reason for the low yield
`lies in the fact that substantial losses of guanylate-rich dodecamers occur during
`chromatography. Chromatography at elevated temperature (45°C) did not increase
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 5
`Page 5
`
`

`

`170
`
`TABLE Hl
`
`H. SCHOTT, R. SEMMLER, H. ECKSTEIN
`
`RESULTS OF THE CHROMATOGRAPHIC PURIFICATION (SEE TABLE I) OF THE DEPROTECTED
`OLIGONUCLEOTIDES
`
`
`lsolated oligodeoxynucleotide
`Oligonucicotide eluted
`Experi-
`
`menttecee oe woe —eenot eee -
`
`
`
`
`No.* Weight—Yield™**Sait Amount Peak Designation
`
`
`
`
`
`
`concentration oteee(Fig. 1} (mg) (%)
`
`(M)
`{A260
`(%)**
`units}
`
`
`18808
`39808
`670
`920
`1350
`4680
`
`I
`
`2
`
`3
`
`3a
`
`4
`
`0.13-0.17
`0.21-0.25
`0.35—0.39
`1.00
`0.23--0.30
`0.42-0.50
`
`0.15-0.18
`0.27-0.30
`0.14-0.16
`0.30-0.33
`
`18.4
`39.0
`14.9
`20.4
`93
`32.2
`
`Not shown
`Not shown
`Not shown
`Not shown
`I{a)
`Ha)
`
`d(G,T,)
`d(TGyT)
`d(TsGq4)
` d(GyT4G,4)
`d(T4G4)
`d(T4Gq4)
`+
`d(T4G4T4Ga)
`d(T4G)
`I(b)
`41.5
`1620
`d(T4G4T4Gq)
`II(b)
`21.0
`820
`2520
`37.6
`l(c)
`d(T,Ga)
`
` 1800 26.9 Il(c) d(T4G4T4G4)
`
`
`
`
`508
`1178
`20
`30
`40
`
`170
`
`50
`30
`70
`55
`
`52.78
`
`7.9
`
`47
`
`22.1
`
`* See Table I.
`** Based on the total amount of the probe applied.
`*** Based on the protected oligonucleotides.
`® Average of three experiments,
`
`the recovery of guanylate-rich oligonucleotides. In this case, extended elution with
`strong buffer solution resulted in a broad second peak of nucleotide material. During
`rechromatography a part of this material was eluted with the normalretention time.
`Similar problems have been reported® when purifying guanylate-rich oligonucleotides
`on Partisil 10-SAX. Even when chromatographing small amounts, other authors?
`have reported unusually low recoveries (40%) from a PEI column in the case of
`oligonucleotides containing three or more consecutive deoxyguanosine monomer
`units.
`
`the deprotected hexadecamer
`Chromatography of small quantities of
`d(T,G4T,G,) on a DEAE-cellulose column yielded no clear peaks in the region
`where octamers and longer-chain oligonucleotides are eluted. The chromatographic
`purification of larger amounts of a hexadecamer was performed as follows. A 700-
`mg amountofthe first hexadecamer, which was synthesized using only one nucleo-
`base protecting group, was deprotected and the d(T,G4T4G,4) obtained was frac-
`tionated on QAE-Sephadex with an increasing gradient of sodium chloride at 25°C,
`according to the conditions given in Tables I, III (experiment 3). The elution profile,
`shown in Fig. la, exhibited two main peaks: 9.3% of the applied Asgo units were
`contained in peak I and amounted to 40 mg d(T4G,)after isolation, peak I] contained
`32%ofthe applied A269 units and 170 mg of a mixture of d(T4G4) and d(T4G4T4G,4)
`(see Table IIT). Furthermore, the elution profile indicates two different shorter-chain
`oligonucleotides eluted previous to the octamer. These oligomeric units might be the
`result of chain degradation, occurring during cleavage ofthe protecting groups. For
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 6
`Page 6
`
`

`

`PURIFICATION OF OLIGODEOXYRIBONUCLEOTIDES
`
`71
`
`the isolation of d(T4G,4T4,Gaq), the mixture corresponding to peak II was rechro-
`matographed on a DEAE-cellulose column, see Table III (experiment 3a), with an
`increasing sodium chloride gradient, containing 7 M urea,at 50°C. The elution profile
`(Fig. 1b) again showed two main peaks, with numerous smaller side peaks forming
`a high baseline. It is remarkable that oligonucleotides were still eluted from the
`DEAE-cellulose column at 50°C with | M sodium chloride, although the same mix-
`ture was eluted from the more basic anion exchanger QAE-Sephadex during the
`separation with 0.42-0.50 M sodium chloride at 25°C (see Fig. la). From the fractions
`corresponding to peak I, containing 42% of the applied A260 units, 50 mg d(T4Ga)
`were isolated. The work-up of peak II, containing 21% of the A360 units applied,
`resulted in 30 mg d(T4G4T4G4), which is only 4.7% of the fully protected hexade-
`camer.
`
`The greatest portion of the deprotected guanylate-rich oligonucleotides was
`lost during the preparative fractionation on the ion exchangers QAE-Sephadex and
`DEAE-cellulose. As clearly demonstrated in Fig. 1a, quite a large part of d(T4G4)
`is associated with d(T4G4T4G,). Therefore both oligonucleotides are eluted together
`within peak II, although the octamerdiffers significantly from the hexadecamerin
`its negative charge. By rechromatography (experiment3a, Fig.
`|b), using 7 M urea
`and a temperature of 50°C, however, d(T4G4) and d(Ts4G4T4G.4) were separated.
`Both 7 M urea and the increased temperature during the elution counteracted the
`formation of aggregates. The high baseline in the elution profile (Fig. 1b) also indi-
`cated that the mixture corresponding to peak IT in Fig. la, besides both main prod-
`ucts, contained additional oligonucleotides of various chain lengths, which are as-
`sociated with the main products. On the other hand, it cannot be excluded that octa-
`and hexadecanucleotides were also eluted in the background. Despite the drastic
`elution conditions, part of the applied mixtures was retarded to such an extent that
`it was not eluted without the use of | M sodium chloride. According to our experi-
`ence, mixtures of corresponding guanylate-poor oligonucleotides do not exhibit such
`difficulties. For example, d(G4T4) could be separated from d(T4G4T4) (see exper-
`iment 1 in Tables I, II1), although these oligonucleotides differ less in their negative
`charges in comparison to d(T4G,4) and d(T4G4T4Ga,
`The purification of a second hexadecamer, which was synthesized using an-
`other strategy, resulted in comparable results. After deprotecting 350 mg of fully
`protected hexadecamer, the solution containing d(T4G4T4G,4) was directly fraction-
`ated on a DEAE-cellulose column at 50°C with an increasing sodium chloride gra-
`dient, containing 7 M urea without any previous separation (see experiment 4, Tables
`I, III). The elution profile (Fig. 1c) generally corresponds to that in Fig. 1b, except
`that the bulk of the shorter-chain oligonucleotides was eluted prior to peak I,
`d(T,G4). Although the first hexadecamer, in contrast to the second one, was syn-
`thesized using guanylate monomer units with doubly protected guanine residues,
`bothsolutions exhibited similar percentages of short-chain oligonucleotides, after the
`protecting group had been cleaved. Because most of these side products had been
`removed during the preseparation of the first hexadecamer (experiment 3, TablesI,
`IID), they are lacking in the elution profile (experiment 3a, Fig. 1b) upon rechroma-
`tography. The fractions corresponding to peak I (Fig. 1c), which contained 37.6%
`of the applied A269 units, amounted to 70 mg d(T4G4). The work-up of peak IT,
`corresponding to 27% of the Aygo units, resulted in 55 mg d(T,G4T4G,). On the
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 7
`Page 7
`
`

`

`172
`
`H. SCHOTT, R. SEMMLER, H. ECKSTEIN
`
`basis of the fully protected component, d(T4G4T4G4) was obtained in 22% yield,
`whereasthe yield of the hexadecamersynthesized according to the other strategy was
`only 4.1%. It cannot be excluded that the low yields result chiefly from the chro-
`matography and not from insufficient protection of the bases during the synthesis.
`The non-specific and irreversible adsorption, which caused the heavy losses of
`the deprotected oligonucleotides on the ion exchangers, occurred also on Nucleosil
`Cig which is commonly used for reversed-phase HPLC ofoligonucleotides. In re-
`versed-phase HPLC on Nucleosil 7 Cig recoveries > 90% could be achieved only
`when analytical amounts (< 3 A269 units) were applied. On applying 30 4369 units,
`only 50% were eluted within the expected region. The other part appeared in sub-
`sequent peaks or even at the end of the gradient. Especially when fractionating
`d(G4T4G,4), identical compounds had different retention times. Finally, we found
`that the totally deprotected oligonucleotides could be separated satisfactorily by ion-
`pair reversed-phase HPLC!°'!3, as described below.
`In order to remove any contamination, HPLC was performed at room tem-
`perature with a preparative Nucleosil 7 C;g column (250 mm x 8 mm I.D.) permit-
`ting up to 60 Az6o units to be fractionated. Elution of the columns was achieved by
`a two-component system (see Table I). The elution was monitored at 260 nm and
`resulted in the elution profiles shown in Figs. 2 and 3. The oligonucleotides d(G,T4)
`and d(T4G4T4) were eluted under isocratic conditions (experiments 1—3) using 7.5
`mM tetrabutylammonium hydrogensulphate (TBA) pH 7.0 as eluent A and 7.5 mA¢
`TBA pH 7.0 in 75% aqueousacetonitrile as eluent B. The oligonucleotides d(T4G,).,
`d(G4TsGy) and d(T,G4T4G,4) were fractionated with a linear increasing gradient
`(experiments 4-6), the concentration of eluent D (5.0 mM TBA pH 6.8 in 70%
`aqueousacetonitrile) increasing from 40 to 80% within 48 min. Eluent C was 5.0
`mM TBApH 6.8. The integration ofthe elution profiles (Figs. 2 and 3) showed that
`the oligonucleotides, except d(G4T,G,4), were contaminated to an extent of less than
`10%, demonstrating that
`the previous column chromatographic separations on
`DEAE-cellulose or QAE-Sephadex led to oligonucleotides of sufficient purity. The
`fractions corresponding to the main peaks within the vertical dotted lines were
`pooled, desalted and lyophilized. As a test of purity, the oligonucleotides were re-
`chromatographed in amounts of 10-15 yg at 50°C on an analytical Nucleosil 7 Cy,
`column (250 mm x 4.6 mm I.D.), e.g.. experiment 2 (Table IT) demonstrates that
`the purity of the isolated oligonucleotides exceed 98%.
`The guanylate-rich d(G4T4G,4), however, could not be purified to an extent
`beyond 60%, by ion exchange or by ion-pair reversed-phase HPLC, as could be
`concluded from the integration of the elution profile (Fig. 3b). It is possible that the
`dodecamer was of much higher purity judging from the elution profile. In support
`ofthis is the elution of identical guanylate-rich oligonucleotidesat different retention
`times, Furthermore, the dodecamercould be used successfully for enzymaticligation,
`as will be described elsewhere’. Therefore contaminations up to the presumed
`amount can certainly be excluded.
`Both the purity and sequence of d(G4T4), d(T,Gq4) and d(T4G4T4) were con-
`firmed by sequencing the oligonucleotides, carried out according to the well known
`two-dimensionalfingerprint method!*~18. Contrary to our expectation,thefingerprint
`method could not be used for the sequencing of d(G4T4G,4) and d(T,4G4T4G,). Be-
`cause of the strong adsorption of the guanylate-rich oligonucleotides on the poly-
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 8
`Page 8
`
`

`

`173
`
`PURIFICATION OF OLIGODEOXY RIBONUCLEOTIDES
`
`
`
`Time in min
`
`Fig. 2. lon-pair reversed-phase HPLC of d(Gq4T4) and d(T4G414) on a Nucleosil 7 Cyg column (250 mm
`x 8mm [.D.) at room temperature underisocratic conditions (see Table IT} with a flow-rate of 2 ml/min.
`(a) d(G4T4) eluted with a mixture of 70% A and 30% B; d(T4G4T4) chromatographed with 50% A and
`50% B.A = 7.5 mAf TBA, pH 7.0: B = 7.5 mAf TBA, pH 7.0 in 75%aqueous acetonitrile.
`
`saccharide matrix, a significant separation of the partial hydrolysates of these oli-
`gonucleotides by means of two-dimensional chromatography failed, thus a finger-
`print could not be obtained. Therefore, the partial hydrolysates of the radioactively
`labelled dodecamer d([°*P]G4T4G4) and hexadecamer d((3?P]T4G4T4G4) were sep-
`arated only one-dimensionally on a polyacrylamide gel under denaturing condi-
`tions'® by meansofelectrophoresis. The separation of the twelve or sixteen spots
`confirmed that the oligonucleotides synthesized indeed correspond to dodecamers
`and hexadecamers, respectively.
`d(T,G4T4G4) was also sequenced according to the method of Maxam and
`Gilbert?° (see Fig. 4). This method is based on a specific chemical modification of
`Cyt, Cyt + Thy, Ade + Gua and Guain four parallel reactions. During the partial
`
`ic)
`
`Aaso '
`
`11i
`
`j
`40
`
`Time in min
`
`Fig. 3. lon-pair reversed-phase HPLCof(a) d(T4G,), (b) d(G4T4Ga,) and (c) d(T4G4T,G4) on a Nucleosil
`7 Cyg column (250 mm x 4.6 mmI,D.) at 50°C with a gradient of 40 to 80% D over 0 to 48 min (see
`Table I); flow-rate:
`| ml/min. C = 5 mM TBA, pH 6.8; D = 5 mM TBAin 70% aqueous acetonitrile.
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 9
`Page 9
`
`

`

`174
`
`H. SCHOTT, R. SEMMLER, H. ECKSTEIN
`
`hydrolysis only the modified nucleobases are supposed to be eliminated and the po-
`lynucleotide chain should be cleaved at the point where these nucleobases are missing.
`Thepartial hydrolysate obtained is separated into fragmentsofdifferent chain lengths
`by gel electrophoresis, resulting in the autoradiogram of Fig. 4. The sequence of the
`hexadecamerfrom the 3’- to the 3’-terminal is obtained by following the most black-
`ened bands in the four lanes from the top (hexadecamer) to the bottom (monomer
`unit). The interpretation of the autoradiogram is given in the right part of Fig. 4.
`The degradation pattern confirms the sequence of d(T4G4T4Gy4). Possible failure
`sequences of synthetic oligonucleotides cannot be detected conclusively and can
`therefore not be excluded. For example, the “C lane”, to which the “Cyt degrada-
`tion” was added for control purposes, contains strong bandsin its upper part, which
`might be correlated with C contaminations. However, this is to be excluded in this
`case, because only T- and G-monomer units have been employed in the synthesis.
`The presence of other nucleobases was independently excluded by totally de-
`grading the hexadecamer chemically. Using formic acid, the oligonucleotide was de-
`graded, according to well known methods?!:?, to its nucleobases. The total hydrol-
`
` C CITAIGG
`
`'
`
`ud
`wn
`WwW
`2
`5
`2
`F
`uy$°
`-@.
`|
`
`.
`1g. ¢
`
`C CAG G
`
`—_—
`—
`—
`—
`—_
`—_—
`_
`a
`
`*pl,Gut, S,
`G3
`Ga
`G
`
`*pl4 Sal,
`T3
`Ty
`T
`
`:
`—"pla Gy
`
`come
`Gg
`=,— _G
`“pla
`8
`a
`
`=
`
`=
`—
`
`the nucleotide-spectific degraded
`Fig. 4. Left part: autoradiogram after gel electrophoresis of
`d((S*P]T4G4T4G.,) using the Maxam and Gilbert method. C, C/T, A/G, G denote C-specific, C + T
`cleavage, A + G cleavage and G-specific cleavage of the oligonucleotide. The chemically degraded oli-
`gonucleotide is fractionated on a “20% polyacrylamide gel” (0.025 cm =x 20cm * 40 cm) with 50 mAf
`Tris-borate—1 m4 EDTA buffer. Electrophoresis proceeded at 2.5 kV/6 mA for 2 h. Right part: inter-
`pretation of the sequence patterns. *p denotes [**P].
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 10
`Page 10
`
`

`

`PURIFICATION OF OLIGODEOXYRIBONUCLEOTIDES
`
`178
`
`ysate was fractionated on a Nucleosil 7 C,g column by means of reversed-phase
`HPLCunderisocratic conditions. Only two peaks were obtained (see Fig. 5b). As is
`seen from the elution profile (Fig. 5a) obtained by chromatography ofthe four nu-
`cleobases underidentical conditions, the retention times (9.76 and 11.69 min) match
`those of Gua (9.77 min) and Thy (11.67 min), respectively. Having found only the
`two nucleobases expected in the total hydrolysate, the presence of other nucleobases
`within the hexadecamer synthesized can be excluded. From the integration of the
`peak areas of Fig. 5b and in view of the molar absorption coefficients at 260 nm
`(Thy, 9600 1 mol~* cm~'; Gua, 13 700 1 mol~! cm~!), a molar ratio of Thy: Gua
`of 1.02:1 was calculated. The nucleobase composition of d(T4G4T4G,) determined
`was very close to that expected (1.00:1).
`
` ¢
` Ade29.16
`
`102030 40
`Time in min
`
`Fig, 5. Reversed-phase HPLC on a Nucleosil 7 C,g column (250mm x 4.6mm I.D.)at room temperature.
`Eluent: 50 m4 ammonium acetate, pH 6.8; flow-rate, | ml/min. Applied probe: (a) the test mixture of the
`four nucleabases Cyt, Gua, Thyand Ade; (b) about 0.1 469 units ofthe totally hydrolysed d(T4G4T4Gu).
`
`CONCLUSIONS
`
`The preparative chromatography of guanylate-rich oligonucleotides, employ-
`ing different separation materials (DEAE-cellulose, QAE-Sephadex, Partisil 10-SAX
`and Nucleosil C,), can be performed only with considerable loss of oligonucleotides.
`Therefore, in the oligonucleotide synthesis there is only a limited possibility of sep-
`arating impurities using chromatography. Guanylate-rich oligonucleotides of dif-
`ferent chain lengths associate with each other, thus causing identical compoundsto
`be contained within different peaks and be eluted from the columnat different times.
`At the same time, part of the product remains irreversibly adsorbed on the ion-
`exchanger matrix. The formation of aggregates between both the oligonucleotides
`and/or their derivatives and between the oligonucleotides and the polymer matrix is
`the reason whythedesired oligonucleotide cannot be obtained when small quantities
`of condensation product are worked up by column chromatography.
`Remarkably, the dodecamer d(G4T4G,4), which couldbe purified only partially
`and characterized not unequivocally, however, resulted in the 36mer and other po-
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 11
`Page 11
`
`

`

`176
`
`H. SCHOTT, R. SEMMLER, H. ECKSTEIN
`
`lynucleotides upon enzymatic ligation with the dodecamer d(T4G4T4)’. This result
`demonstrates that the oligonucleotides can be used in enzymatic reactions directly
`after their synthesis, without tedious final purification. Also that the common en-
`zymatic reactions employing oligonucleotides do not require an high standard of
`purity, because the enzymes are able to select the “fitting compound” from the mul-
`titude offered.
`The increasing demand for oligonucleotides necessitates their preparation in
`large amounts. Therefore, preparative synthesis on the largest scale possible is an
`urgent objective. In our opinion there is no need for considerable improvements in
`the strategy of the oligonucleotide synthesis, but there is a great demand for more
`efficient separation methods for purifying the oligonucleotides after the deprotection
`without major losses.
`
`ACKNOWLEDGEMENT
`
`This work was suported by the Deutsche Forschungsgemeinschaft.
`
`REFERENCES
`
`1 H. J. Lipps and P, Erhardt, FEBS Lezt., 126 (1981) 219.
`2 H. J. Lipps, W. Gruissem and D. M. Prescott, Proc. Natl. Acad. Sci. U.S.A,, 79 (1982) 2495.
`3 R. F. Boswell, L. A. Klobutcher and D. M. Prescott, Proc. Nati. Acad. Sci. U.S.A., 79 (1982) 3255.
`4 D. Dawson and G. Herrick, Cel/, 36 (1984) 171.
`5 D. Dawson and G. Herrick, Mol. Cell. Biol., 4 (1984) 2661.
`6 E. Helftenbein, Nucleic Acids Res., 13 (1985) 415.
`7 H. Schott, R. Semmler, K. Closs and H. Eckstein, Makromol. Chem., in press.
`8 M.D. Edge, A. R. Greene, G. R. Heathcliffe, PA. Meacock, W. Schuch, D. B. Scanlon, T.C. Atkinson,
`C.R. Newton and A. F. Markham, Nature (London), 292 (1981) 756.
`9 T. G. Lawson, F. E. Regnier and H. L. Weith, Anal. Biochem., 133 (1983) 85.
`10 I. M. Johansson, K.-G. Wahlund and G. Schill, J. Chromatogr., 149 (1978) 281,
`tl J. H. Knox and J. Jurand, J. Chromatagr., 149 (1978) 297.
`12 A. Tilly Melin, M. Ljungerantz and G.Schill, J. Chromatogr., 185 (1979) 225.
`13 M.Kwiatkowski, A. Sandstrom, N. Balgobin and J. Chattopadhyaya, Nucleic Acids Res. Symp. Ser.,
`No. 14 (1984).
`14 E. Jay, R. Bambara, R.Padmanabhan and R. Wu, Nucleic Acids Res.,
`15 C.D.Tu, E. Jay, C.P.Bahl and R.Wu, Anal. Biochem., 74 (1976) 73.
`16 R. Frank and H. Blocker, in H.G. Gassen and A. Lang (Editors), Chemical and Enzymatic Synthesis
`of Gene Fragments, Verlag Chemie, Weinheim, 1982, p. 225.
`17 H. Schott and H. Schrade, J.Chromatogr., 284 (1984) 381.
`18 H. Schott, H. Schrade and H.Watzlawick, J. Chromatogr., 285 (1984) 343.
`19 T. Maniatis, A. Jeffrey and H. van de Sande, Biochemistry, 14 (1975) 3787.
`20 A.M. Maxam and W. Gilbert, Merhods Enzymol., 65 (1980) 499,
`21 C.Y. Ko, J. L. Johnson, L. B. Barnett, H. M. MeNair and J. R. Vercelotti, Anal. Biochem, 80 (1977)
`183.
`22H. J. Fritz, D. Eick and W. Werr, in H. G. Gassen and A. Lang (Editors), Chemical and Enzymatic
`Synthesis of Gene Fragments, Verlag Chemie, Weinheim, 1982, p. 199.
`
`| (1974) 331.
`
`CUREVAC EX2041
`CUREVAC EX2041
`Page 12
`Page 12
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket